Array ( [1575947552] => Array ( [wordfence_hourly_cron] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1575947873] => Array ( [wp_session_garbage_collection] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1575949173] => Array ( [wp_privacy_delete_old_export_files] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1575949681] => Array ( [wpm_update_stats] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1575961712] => Array ( [ai1wm_storage_cleanup] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1575967771] => Array ( [wp_scheduled_auto_draft_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1575972911] => Array ( [delete_expired_transients] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1575972952] => Array ( [wpseo-reindex-links] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1575979952] => Array ( [wordfence_daily_cron] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1575984726] => Array ( [wp_update_themes] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) [wp_version_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) [wp_update_plugins] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1575985474] => Array ( [wp_scheduled_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1575985799] => Array ( [wordfence_start_scheduled_scan] => Array ( [e514cb7e61cfdbf907537c414b5c3be7] => Array ( [schedule] => [args] => Array ( [0] => 1575985799 ) ) ) ) [1575994024] => Array ( [akismet_scheduled_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1575997011] => Array ( [yoast_tracking] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1576244999] => Array ( [wordfence_start_scheduled_scan] => Array ( [44d43aa69033fca61c02407c6c65d4d4] => Array ( [schedule] => [args] => Array ( [0] => 1576244999 ) ) ) ) [1576508400] => Array ( [wordfence_email_activity_report] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => [args] => Array ( ) ) ) ) [1580169600] => Array ( [publish_future_post] => Array ( [2d492587fa52e9c78f7043ddf937b0a1] => Array ( [schedule] => [args] => Array ( [0] => 18611 ) ) [dea3edad73162f380bc9dc44fa3407bf] => Array ( [schedule] => [args] => Array ( [0] => 19670 ) ) [2caa9c58a241c4f77a6856802c1b43fb] => Array ( [schedule] => [args] => Array ( [0] => 20734 ) ) [307b37ba29b8cd716eafa809661756e3] => Array ( [schedule] => [args] => Array ( [0] => 22852 ) ) [365be9eba8e62abb0c0d4bfe013a2687] => Array ( [schedule] => [args] => Array ( [0] => 23918 ) ) [0e942b20ffb9550322105263ad82126f] => Array ( [schedule] => [args] => Array ( [0] => 24977 ) ) [661c5eb39689fe2133ff7986ac6628fb] => Array ( [schedule] => [args] => Array ( [0] => 26036 ) ) [75562b264e355915e4dea97042a28f7e] => Array ( [schedule] => [args] => Array ( [0] => 27095 ) ) [11cf4e8a6f842b0115881551a29c47f6] => Array ( [schedule] => [args] => Array ( [0] => 28154 ) ) [55a38aaca11da398c854cb29a7d4f5e6] => Array ( [schedule] => [args] => Array ( [0] => 30272 ) ) [f8cbc904676c235c7057ec965c01c023] => Array ( [schedule] => [args] => Array ( [0] => 32390 ) ) ) ) [1583794819] => Array ( [publish_future_post] => Array ( [9d993985746691420cd7524448c48a23] => Array ( [schedule] => [args] => Array ( [0] => 448880 ) ) ) ) [1601157627] => Array ( [publish_future_post] => Array ( [aa3f9c41dd8e97586795881a0c603b8d] => Array ( [schedule] => [args] => Array ( [0] => 472787 ) ) ) ) )
Etiquetas: Agencia española de medicamentos y productos sanitarios, Año 2010, Enero 2011, Industria farmacéutica, Investigación Clínica, Madrid, medicamentos, Modificaciones, Nombre comercial, Noticias y temas de interés, Novedades terapéuticas, Nuevas indicaciones autorizadas, Nuevas indicaciones en medicamentos, Nuevos medicamentos, Oferta de medicamentos, Principio activo, Profesionales sanitarios, salud, Sanidad, Sistema Nacional de Salud, SNS, Subgrupo, Volumen 35.
Utilizamos cookies propias y de terceros para recopilar información que ayuda a optimizar su visita. Las cookies no se utilizan para recoger información de carácter personal. Usted puede permitir su uso o rechazarlo, también puede cambiar su configuración siempre que lo desee. Al continuar con la navegación entendemos que se acepta nuestra política de cookies.
x